Close Window

Digital Look Email A Friend

AstraZeneca to buy US-listed Fusion Pharma for $2bn

Published by Frank Prenesti on 19th March 2024

(Sharecast News) - AstraZeneca said it had agreed to buy biopharmaceutical company Fusion Pharmaceuticals for up to $2bn.

URL: http://www.digitallook.com/dl/news/story/34163936/...

Email this article to your friends
NOTE: These email addresses will be used to email the information on your behalf and will not be collected by Digital Look for any marketing purposes.